Recent advances and emerging mechanisms in graphene-based materials for cartilage tissue engineering Authors: Mone’t Sawyer, David Estrada Published: 2026 ABSTRACT Graphene-based materials offer tunable mechanical, electrical, and biochemical properties that address longstanding challenges in cartilage tissue engineering. This review synthesizes recent advances in graphene derivatives, scaffold fabrication strategies, and emerging mechanisms governing cell–graphene interactions. We evaluate how graphene enhances mechanical reinforcement, bioactivity, and matrix production across hydrogels, polymer composites, and ECM-derived scaffolds. Key opportunities and translational pathways are identified to guide the development of next-generation cartilage regeneration technologies. Introduction Articular cartilage (AC) is a highly specialized connective tissue composed of a sparse population of chondrocytes embedded in a dense extracellular matrix (ECM) rich in collagen and proteoglycans1. AC lines the surfaces of synovial joints and is uniquely adapted to provide load-bearing support and near-frictionless articulation during movement2. The ECM of AC can be further divided into the pericellular, territorial, and interterritorial zones3. The tissue’s anisotropic structure enables it to resist compressive forces while maintaining tensile integrity and minimizing shear stress at the joint surfaces4. Unlike most tissues, AC is avascular and lacks lymphatics or nerves1,5. As a result, it exhibits a limited capacity for self-repair following injury6. Osteoarthritis (OA) – a degenerative joint disease marked by the erosion of AC in diarthrodial joints – is recognized as a major global health burden, affecting over 595 million individuals worldwide7. The knee joint is disproportionately affected, particularly in adults over 45, where OA can lead to chronic pain, inflammation, and irreversible loss of joint function8. The limited self-repair capacity of cartilage, combined with the growing prevalence and socioeconomic impact of OA, underscores the need for therapies that restore native tissue structure and function9. Treatment strategies for OA vary depending on symptom severity and patient profile10. Non-surgical interventions focus on pain management and functional improvement but do not repair the damaged tissue. Surgical treatments are employed when conservative approaches fail or when defects are more extensive11. These include arthroscopic debridement, which removes unstable cartilage fragments, and microfracture, promoting fibrocartilage repair via marrow-derived mesenchymal stromal cells12. Larger lesions are managed with autologous chondrocyte implantation or osteochondral grafting, using either autografts or allografts to replace the defect with viable cartilage and bone13. Total knee arthroplasty (TKA) remains the primary treatment for patients with end-stage OA. In this procedure, the damaged articular surfaces are replaced with a metal femoral component and a highly crosslinked polyethylene tibial insert14,15. While TKA significantly improves pain and mobility, outcomes may vary by patient age, sex, and activity level. Complications such as infection, implant failure, or suboptimal function can occur, and 10–20% of patients report dissatisfaction with long-term results16,17. Despite these limitations, long-term implant survival remains strong, with approximately 82.3% of TKAs still functional at 25 years14. Beyond this timeframe, however, the risk of revision surgery increases due to aseptic loosening, infection, or other mechanical failures18. Despite the widespread use of these interventions, none reliably restore the complex structural, biochemical, and mechanical properties of native AC. Many regenerative efforts yield fibrocartilage with inferior mechanical properties. Tissue engineering (TE) has emerged as a promising alternative, integrating cells, biomaterial scaffolds, and biochemical or biophysical cues to recreate the native cartilage microenvironment. Scaffold materials are central to providing structural support and to passively or actively guiding cell behavior19. A significant challenge in TE is achieving the optimal balance among material strength, biocompatibility, and bioactivity20. Natural polymers such as collagen and hyaluronic acid offer biological relevance but insufficient mechanical strength21. Synthetic materials like polycaprolactone (PCL) provide mechanical strength and structural tunability yet lack intrinsic bioactivity22,23. Hydrogels support cell encapsulation and nutrient transport but typically have low mechanical strength and fracture energies (< 15 J m−2)24. These limitations underscore the need for next-generation materials capable of active cellular communication, structural mimicry, and robust mechanical performance25. The Fundamentals of Graphene and Its Chemical Derivatives Graphene and its chemical derivatives have emerged as candidates for cartilage TE. With their mechanical stiffness, high surface area-to-volume ratio, variable electrical conductivity, and tunable surface chemistry, graphene-based materials can enhance biomaterial functionality26. This review examines the role of graphene-based materials in AC TE, highlighting their integration into hydrogels and polymer composites, functionalization of ECM-derived scaffolds, use as three-dimensional (3D) foams, and emerging mechanistic insights into cell-graphene interactions. We further assess how these systems are characterized and benchmarked against the requirements of native cartilage, identifying opportunities for innovation in materials design and biological application. Throughout this review, ‘graphene-based materials’ and ‘graphene derivatives’ are used as umbrella terms for the material family; when a specific study, property, or mechanism is discussed, the specific derivative (graphene, GO, rGO, FLG, or graphene foam) is named, because these materials differ in surface chemistry, conductivity, and biological behavior. Structure and Properties of Graphene and Its Derivatives Graphene, an allotrope of carbon, consists of a single atomic layer of sp2-bonded carbon atoms arranged in a hexagonal lattice. In its pristine monolayer form, graphene exhibits extraordinary mechanical (Young’s Modulus ~1 TPa), electrical (>15,000 cm2 V−1 s−1 at room temperature), and thermal (~3000 Wm−1 K−1) properties, largely due to strong C-C bonding, its extended conjugated sp2 carbon network, and high acoustic phonon velocities26–29. However, various chemical derivatives have been developed to tailor these properties for specific applications, including few-layer graphene (FLG), multilayered graphene sheets, 3D graphene foams and aerogels, graphene oxide (GO), and reduced graphene oxide (rGO) (Fig. 1)30–33. Defects and layer-number control are critical for modulating key material characteristics such as electrical conductivity, optical transparency, surface energy, and mechanical stiffness34,35.Fig. 1Common chemical derivatives and architectures of graphene.a Two-dimensional derivatives GO, produced via oxidative functionalization of pristine graphene, and rGO, generated through the partial removal of oxygen-containing groups. Adapted from Bellier et al., under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0)31. b Three-dimensional graphene architectures include graphene aerogels and graphene foams, both characterized by highly porous microstructures. Common chemical derivatives and architectures of graphene. a Two-dimensional derivatives GO, produced via oxidative functionalization of pristine graphene, and rGO, generated through the partial removal of oxygen-containing groups. Adapted from Bellier et al., under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0)31. b Three-dimensional graphene architectures include graphene aerogels and graphene foams, both characterized by highly porous microstructures. These tunable properties make graphene and its derivatives attractive for biomedical applications. For instance, the high electron mobility and excellent mechanical properties of monolayer and FLG films support mechanosensitive cell signaling and cytoskeletal organization36. Due to their unique combination of electrical conductivity and optical transparency, 2D graphene materials have been employed to fabricate neural microelectrodes that support multimodal interrogation of neural activity, allowing simultaneous electrical stimulation, optical imaging, and surface electrophysiological recording37–39. In contrast, 3D graphene derivatives feature interconnected microporous architectures that facilitate nutrient diffusion, waste exchange, and spatial cell organization, while providing a large surface area for cell attachment in TE (Fig. 1b)40. These features position graphene-based materials as promising platforms for guiding cell behavior, enhancing ECM production, and supporting lineage-specific differentiation, laying the foundation for their multifaceted role in cartilage TE41,42. Synthesis of graphene and its chemical derivatives The fabrication methods for graphene and its chemical derivatives have a profound influence on atomic and microstructural features, physiochemical properties, and biological performance in TE applications43,44. Graphene can be synthesized through various bottom-up and top-down approaches, each with distinct advantages and limitations relevant to biomedical applications. Bottom-up synthesis of graphene via Chemical Vapor Deposition (CVD) The primary method for fabricating high-quality graphene films and 3D graphene foams is CVD45. As illustrated in Fig. 2a, a metal catalyst such as copper or nickel is exposed to a carbon-containing gas (e.g., methane, toluene) at high temperatures46,47. Carbon atoms decompose from the gas and self-assemble into a hexagonal graphene lattice on the metal surface. A wet etch process is then used to remove the metal template, yielding freestanding graphene films or porous foams with tunable architectures, surface features, and material properties45,48,49.Fig. 2Common synthesis methods for graphene and its derivatives.a CVD involves the decomposition of a carbon precursor over a heated metal substrate to generate few- or multilayer graphene films or 3D foams. b Epitaxial growth on SiC involves high-temperature sublimation of silicon atoms, leaving behind an ordered graphene layer on the substrate surface. c LPE separates graphene layers from bulk graphite using solvent-assisted sonication. d Electrochemical exfoliation applies voltage across graphite in an electrolyte solution to intercalate ions and separate graphene layers via gas evolution and ionic repulsion. Figure created with Biorender.com. Common synthesis methods for graphene and its derivatives. a CVD involves the decomposition of a carbon precursor over a heated metal substrate to generate few- or multilayer graphene films or 3D foams. b Epitaxial growth on SiC involves high-temperature sublimation of silicon atoms, leaving behind an ordered graphene layer on the substrate surface. c LPE separates graphene layers from bulk graphite using solvent-assisted sonication. d Electrochemical exfoliation applies voltage across graphite in an electrolyte solution to intercalate ions and separate graphene layers via gas evolution and ionic repulsion. Figure created with Biorender.com. CVD-synthesized graphene typically ranges from monolayer to few-layer structures in planar films and from few-layer to multi-layer configurations in 3D graphene foams49,50. This structural variability yields a distinctive combination of properties, including exceptional carrier mobility, mechanical flexibility, and thermal stability, which are highly advantageous for bioengineering applications. Moreover, CVD is considered one of the more environmentally sustainable and economically scalable methods for producing high-quality graphene, supporting its use in translational and industrial biomedical platforms51. Beyond metal-catalyzed CVD routes, recent advances demonstrate that graphene can also be synthesized directly on sapphire substrates at the wafer scale, offering a catalyst-free pathway compatible with semiconductor manufacturing. Mishra et al. demonstrated that hydrogen-etched c-plane sapphire exposed an Al-rich surface that catalyzes graphene growth at conventional CVD temperatures in commercially available reactors, resulting in high-quality monolayer graphene52. This process eliminates the need for metal transfer steps, yielding low-contamination, highly crystalline, low-defect graphene suitable for device integration. The demonstrated scalability and film homogeneity, together with the compatibility of sapphire wafers with existing fabrication infrastructure, position this approach as a viable route for producing high-quality graphene at industrially relevant dimensions53. While CVD-grown graphene on sapphire does not address the structural needs of 3D tissue engineering, it could provide a robust platform for biomedical technologies that benefit from high-quality planar films, including sensitive biosensors, neural interfaces, drug-delivery components, and antimicrobial surface coatings. Epitaxial Growth from Silicon Carbide (SiC) Epitaxial graphene, an alternative to CVD graphene, is synthesized via thermal decomposition of SiC substrates, producing high-quality graphene films directly on the semiconducting surface54–56. In this process, silicon atoms sublimate from the SiC crystal at elevated temperatures, leaving behind a carbon-rich surface that reorganizes into a highly ordered hexagonal lattice (Fig. 2b)57. Due to the structural symmetry between SiC and graphene, the substrate serves both as a carbon source and a template, enabling the formation of uniform, low-defect graphene layers over large areas58. This synthesis method produces atomically thin, highly crystalline graphene that remains strongly adhered to the SiC substrate, eliminating the need for post-synthesis transfer. The intimate interface between the graphene and SiC is especially advantageous for applications requiring seamless integration with solid-state devices59,60. This method confers the ability to control layer number during growth and allows for fine-tuning of the electronic band structure and surface energy, relevant to bioelectronic implants and diagnostic devices61,62. Despite these advances, the use of epitaxial graphene in TE remains limited, with barriers that include high fabrication costs, the rigidity of the SiC substrate, and challenges in producing freestanding or porous structures for use in 3D scaffold systems. Nonetheless, epitaxial graphene shows considerable promise for biomedical microdevices where electrical consistency and structural stability are essential. It has been explored in biosensing platforms and electrophysiological interfaces, where direct coupling to electronic circuitry is beneficial63–65. As such, epitaxial graphene remains a relevant part of the broader landscape of graphene synthesis methods, particularly for future biomedical technologies that integrate sensing, stimulation, and biocompatible interfacing. Top-down synthesis of graphene by exfoliation of graphite Graphite exfoliation is a widely used top-down method to produce FLG, particularly for applications prioritizing scalability, cost-effectiveness, and compatibility with additive manufacturing techniques66. By exploiting the weak van der Waals forces between adjacent graphene layers in bulk graphite, exfoliation enables the separation of individual or FLG sheets while preserving much of the sp2 carbon structure and intrinsic properties of pristine graphene67. These exfoliation techniques favor applications that require aqueous dispersibility and compatibility with soft materials, such as printed electronics, flexible biosensors, and additive scaffold manufacturing. Graphite yield, flake quality, dispersibility, and defect density are all affected by the method of exfoliation. The three most prominent exfoliation methods are detailed in this section. Liquid-phase exfoliation (LPE) is a scalable and widely used technique for producing monolayer and FLG by dispersing graphite in solvents and applying high-energy inputs such as ultrasonication, microfluidization, or high-shear33,68–70. The mechanical agitation disrupts interlayer attractions, delaminating graphite into nanosheets without extensive structural disruption (Fig. 2c)71. Exfoliation efficiency and flake quality depend on solvent polarity, energy intensity, and post-processing parameters such as centrifugation72,73. Notably, LPE avoids chemical oxidation, allowing for better preservation of the graphene’s extended π-conjugated structure, which underpins its electrical conductivity and mechanical integrity. This method is commonly employed to produce graphene dispersions for conductive films, printable inks, and composites74. Electrochemical exfoliation of graphite is a high-yield method for producing FLG via electrochemical ion intercalation and gas-driven delamination. In a two-electrode setup, a graphite working electrode is immersed in an aqueous electrolyte and biased with a potential that drives either anodic (graphite is positively biased) or cathodic (graphite is negatively biased) exfoliation (Fig. 2d)66. In anodic exfoliation, a positive current withdraws electrons from the graphite working electrode, leading to the intercalation of bulky negative ions (e.g., SO42-) and increased interlayer spacing between graphene sheets, which then aids in the subsequent exfoliation75,76. In cathodic exfoliation, the negative bias attracts positively charged ions (e.g., Li+), similarly increasing the intercalating species between graphene sheets, causing expansion and exfoliation77. This process yields graphene with moderate oxygen content and tunable surface chemistry, depending on the electrolyte composition, voltage range, and duration. The resulting material often exhibits enhanced aqueous dispersibility and is suitable for further reduction or functionalization, making it a promising intermediate for both conductive and bioactive graphene-based systems. Following exfoliation, the resulting polydisperse graphene nanosheets can be further refined to obtain fractions with controlled layer numbers and thickness distributions. Density gradient ultracentrifugation enables the separation of graphene subpopulations based on sedimentation coefficients and buoyant density, producing narrower, application-specific distributions of flakes78,79. These sorted dispersions can be formulated into functional inks compatible with inkjet, aerosol jet, plasma jet, and related additive manufacturing modalities80–83. Such graphene-based inks and fabrication methods enable high-resolution fabrication of electrochemical and biosensing electrodes84. Chemical exfoliation describes the intercalation of reactive species into graphite to expand interlayer spacing and facilitate the subsequent delamination of graphene sheets. This method fully disrupts the graphitic system to produce graphene oxide (GO), a highly functionalized graphene derivative widely used for biomedical research85,86. The most common method is the Hummers’ method and its variants, which use strong oxidants such as potassium permanganate in concentrated sulfuric acid to insert oxygen-containing functional groups (e.g., hydroxyl, epoxy, carboxyl) between graphite layers87. The oxidation induces extensive lattice distortion and increases interlayer spacing, facilitating exfoliation into single- or few-layer GO sheets upon ultrasonication88. GO is hydrophilic, readily dispersible in water, and offers abundant chemical handles for biomolecular conjugation or polymer integration, but it exhibits reduced electrical conductivity due to sp2-bond disruption89. To partially restore conductivity while retaining surface functionality, GO can be chemically, thermally, or photochemically reduced to form reduced graphene oxide (rGO)90. Reduction removes a portion of the oxygen groups and recovers π-conjugation, resulting in a heterogeneous material with mixed sp2/sp3 domains and tunable physiochemical properties91. The balance between functionalization and conductivity in GO and rGO makes them among the most widely used graphene-based materials in TE applications, particularly for hydrogels, electroactive scaffolds, and drug delivery platforms. Laser-Induced Graphene Laser-induced graphene (LIG) offers a fundamentally different route to graphene fabrication, enabling direct patterning of conductive porous graphene networks from inexpensive carbon-rich precursors. Lin et al. demonstrated that polyimide films exposed to a CO2 infrared laser undergo rapid photothermal conversion, where localized temperatures exceeding 2500 °C break C-O bonds and C-N bonds and reorganize the carbon framework into sp2-dominated, few-layer graphene architectures92. The resulting material forms a mechanically robust, hierarchically porous foam with high conductivity and a 3D morphology that increases accessible surface area. Recent developments have broadened LIG’s precursor materials and expanded its utility across flexible electronics, biosensing, environmental monitoring, and micro-energy storage93–95. LIG can be generated on polyimide, polyetherimide, lignin-based films, paper, and textiles, enabling one-step fabrication of graphene electrodes with tunable porosity and controllable defect densities96. The attributes of LIG, coupled with a variety of precursor substrates, position the material as a versatile, digitally patternable, and commercially relevant graphene synthesis strategy that complements both bottom-up CVD and top-down exfoliation approaches in next-generation biomedical and electronic device manufacturing, with recent studies evaluating the efficacy of LIG for skeletal muscle and cardiac tissue engineering applications97,98. Graphene-Based Scaffolds for Cartilage Tissue Engineering The regeneration of AC requires biomaterials that closely mimic the structure and function of native ECM, supporting cell adhesion, differentiation, and matrix deposition99,100. Graphene-based materials can be processed into diverse scaffolds, including injectable hydrogels and printable composites, functionalized ECM-derived matrices, and free-standing 3D foams – each offering distinct advantages for promoting stem cell differentiation, phenotype maintenance, and tissue integration42,101. This section reviews current strategies for incorporating graphene derivatives into biomaterial scaffolds for in vitro cartilage TE, with an emphasis on scaffold design, functional performance, and biological outcomes. Fabrication methods for graphene-based scaffolds The fabrication method used to integrate graphene into scaffolds significantly influences scaffold architecture, porosity, mechanical behavior, and biological performance102. Leveraging diverse synthesis routes, graphene derivatives have been incorporated into a variety of scaffold formats using fabrication strategies such as 3D bioprinting, freeze-drying, electrospinning, and mold-based casting103–107. In parallel, free-standing constructs like graphene foams and aerogels can be produced using CVD or hydrothermal self-assembly, yielding highly porous and conductive structures ideal for electrical stimulation and load-bearing support40,108. These methods allow fine control over key structural features such as pore size, interconnectivity, and scaffold stiffness, which are essential for facilitating nutrient transport, cell migration, and mechanical reinforcement in cartilage TE109,110. Graphene-based mechanical reinforcement strategies Hydrogels and polymer scaffolds are widely used in cartilage TE due to their biocompatibility and ECM-mimetic properties111. While AC is adapted to resist dynamic mechanical loading, hydrogels often deform under similar stresses, limiting their ability to mimic the environment of native AC and affecting mechanotransduction in in vitro applications112. Strategies for tuning hydrogel stiffness, such as chemical crosslinking, can compromise cell viability, impede migration, and reduce biomolecule diffusion, thereby undermining the regenerative potential113,114. Graphene-based nanomaterials, particularly GO and rGO, have been incorporated into synthetic and natural biomaterials to address these limitations. These additives form hydrogen bonds, enhance polymer chain entanglement, and enable more uniform stress distribution, collectively improving stiffness, toughness, and fatigue resistance (Fig. 3). This section reviews the role of graphene derivatives in reinforcing cartilage scaffold materials, categorized by synthetic polymer composites and natural or ECM-derived constructs.Fig. 3Example of the preparation process for PVA/PAA/GO hydrogels and the crosslinking and bonding mechanisms that result in improved lubrication and durability properties117. Adapted from Feng et al., Copyright 2024 Elsevier Ltd. License Number: 6194341407748. Example of the preparation process for PVA/PAA/GO hydrogels and the crosslinking and bonding mechanisms that result in improved lubrication and durability properties117. Adapted from Feng et al., Copyright 2024 Elsevier Ltd. License Number: 6194341407748. Synthetic polymer and hydrogel composites GO integrated into synthetic hydrogel and polymer matrices has been widely shown to enhance the mechanical properties of scaffolds across diverse material systems115. Meng et al. demonstrated that the addition of GO to polyvinyl alcohol (PVA)/polyethylene glycol (PEG) freeze-dried scaffolds increased the formation of crystalline regions, thereby elevating the effective crosslinking density in a concentration-dependent manner116. Mechanical testing revealed approximately 200% higher tensile strength, 40% increase in elongation at break, and a 100% increase in compressive modulus compared to PVA-PEG controls. These improvements were attributed to uniform GO dispersion and the formation of hydrogen bonds between the GO and the PVA matrix. In a related study, Feng et al. reinforced a PVA-polyacrylic acid (PAA) hydrogel with GO and reported a 1.5-fold increase in tensile strength and a 1.35-fold increase in elastic modulus (Fig. 4a, b)117. The resulting PVA/PAA/GO composite reached compressive strengths within the physiological range of native AC and withstood 500,000 friction cycles, supporting its potential use in load-bearing cartilage repair (Fig. 4c, d).Fig. 4Mechanical characterization of PVA/PAA/GO composites for cartilage tissue engineering applications.a Comparative stress-strain tensile curves for PVA/PAA/GO, PVA/GO, PVA/PAA, and PVA hydrogels. b Comparative stress-strain compressive curves for the same materials in (a). c Curves for COF over time for the hydrogels tested in tension and compression. d Friction mechanism employed to acquire COFs in this study117. Adapted from Feng et al. Copyright 2024 Elsevier Ltd. License Number: 6194350116798. Mechanical characterization of PVA/PAA/GO composites for cartilage tissue engineering applications. a Comparative stress-strain tensile curves for PVA/PAA/GO, PVA/GO, PVA/PAA, and PVA hydrogels. b Comparative stress-strain compressive curves for the same materials in (a). c Curves for COF over time for the hydrogels tested in tension and compression. d Friction mechanism employed to acquire COFs in this study117. Adapted from Feng et al. Copyright 2024 Elsevier Ltd. License Number: 6194350116798. Other synthetic systems have demonstrated comparable improvements in mechanical performance following GO incorporation. More et al. developed electrospun GO-reinforced poly (3-hydroxybutyrate-co-3-hydroxy valerate) (PB) scaffolds to evaluate the effects of GO on mechanical behavior, piezoelectricity, and bioactivity118. Mechanical performance was shown to be concentration dependent, with scaffolds containing 1.5 wt% GO exhibiting a tensile strength of 2.08 ± 0.33 MPa, compared to 0.59 ± 0.12 MPa in the GO-free PB controls. GO also significantly enhanced the piezoelectric coefficient. These improvements were attributed to uniform GO dispersion and enhanced interfacial stress transfer within the polymer matrix; however, at higher GO concentrations, mechanical strength declined, likely due to GO aggregation (Fig. 5).Fig. 5Tensile testing and microstructure of PB and PB-GO nanofibrous electrospun scaffolds.a Tensile strength of scaffolds based on GO concentration and (b) stress-strain behavior for PB and PB-GO scaffolds. SEM images of (c) PB, (d) PB-0.5GO, (c) PB-1.0GO, (e) PB-1.5GO, and (g) PB-2.0GO118. Adapted from More et al., Copyright 2020 American Chemical Society. License Number: 6194351291091. Tensile testing and microstructure of PB and PB-GO nanofibrous electrospun scaffolds. a Tensile strength of scaffolds based on GO concentration and (b) stress-strain behavior for PB and PB-GO scaffolds. SEM images of (c) PB, (d) PB-0.5GO, (c) PB-1.0GO, (e) PB-1.5GO, and (g) PB-2.0GO118. Adapted from More et al., Copyright 2020 American Chemical Society. License Number: 6194351291091. A distinct approach was taken by Trucco et al., who developed a bilayered scaffold composed of GO-doped gellan gum (GG) and poly (ethylene glycol) diacrylate (PEGDA) to mimic the mechanical and lubricative properties of the superficial and deep zones of AC107. GO was incorporated at 0.01% (w/v) into the superficial GG layer. While the addition of GO did not significantly alter the elastic modulus, it increased the fracture stress from 194 ± 27 to 246 ± 34 kPa, suggesting enhanced energy dissipation and resistance to mechanical failure. The scaffold maintained its zonal architecture and mechanical integrity over 100,000 friction cycles, and GO-containing constructs exhibited a lower coefficient of friction (0.018 ± 0.004) compared to non-doped controls (0.025 ± 0.003) in synthetic synovial fluid, suggesting improved tribological behavior under joint-like loading. While GO is beneficial for biocompatibility and the aforementioned applications, its use compared with other graphene derivatives comes at the expense of electrical properties. Natural and ECM derived scaffolds Beyond synthetic polymers, GO and rGO have also been integrated into natural and hybrid biomaterials to improve mechanical resilience while preserving bioactivity. Chitosan, a derivative of chitin, is a material of interest in cartilage TE due to its customizable structural, physiochemical, and biological properties, though its intrinsic mechanical strength remains limited119. Kosowska et al. evaluated the incorporation of GO and rGO into chitosan films and reported that GO increased the Young’s modulus by 35% relative to pure chitosan. In contrast, rGO samples exhibited divergent behavior depending on the reduction method using nontoxic reagents. rGO reduced with grape or tea extract before incorporation into chitosan resulted in a decrease in Young’s modulus. In contrast, rGO reduced with L-ascorbic acid stabilized the polymer network with increased crystallinity, producing films with greater flexibility and reduced brittleness, despite having the lowest overall modulus120. These findings highlight the importance of the graphene surface chemistry in tuning both stiffness and ductility. Decellularized and ECM-derived scaffolds have also been reinforced with GO to restore mechanical integrity, which is often reduced during processing121. Gong et al. developed a GO-modified acellular cartilage ECM (ACM) scaffold and evaluated its performance both in vitro and in vivo106. The scaffold’s compressive elastic modulus increased with GO concentration, with the 6 mg/mL GO group reaching 0.217 ± 0.007 MPa, nearly five times that of the control group (0.043 ± 0.002 MPa) without compromising porosity. SEM imaging revealed a more uniform and interconnected pore architecture than ACM alone, and thermogravimetric analysis confirmed enhanced thermal stability (Fig. 6a). In a complementary approach, Mou et al. fabricated a bilayered GO-collagen (GO-COL)/nano-hydroxyapatite (nHAP) composite scaffold via freeze-drying122. The cartilage layer contained 0.05 wt% GO and 2 wt% collagen, while the bone layer included 0.2 wt% GO, 0.5 wt% nHAP, and 2 wt% collagen. To emulate the osteochondral interface, the respective layers were coated with either chondrogenic ECM (CgECM) or osteogenic ECM (OgECM) sheets (Fig. 6b, c, e). Compressive moduli of the bilayers were evaluated via dynamic fatigue testing, revealing that the bone layer had a Young’s modulus of 0.979 ± 0.132 MPa, substantially higher than that of the cartilage layer (0.199 ± 0.059 MPa) (Fig. 6d). Although the independent effects of the nHAP and GO were not isolated, the results demonstrate that matrix composition and GO content can be tuned to match the layered mechanical requirements of osteochondral tissue. Table 1 summarizes the scaffold systems, graphene derivatives, loading concentrations, fabrication routes, and principal outcomes for the studies discussed in Section 3.Fig. 6GO incorporation into ECM-based scaffolds.a SEM imaging of ACM and GO scaffolds before (-) and after (+) crosslinking at i & vi) 0 mg/mL, ii & vii) 1 mg/mL, iii & viii) 2 mg/mL, iv & ix) 4 mg/mL, and v & x) 4 mg/mL concentrations. Adapted from Gong et al., Copyright 2020 Elsevier B.V. 2020. License Number: 6194351389673. b Schematic diagram of biphasic CgECM and OgECM scaffolds. c Macroscopic view of the assembled biphasic ECM scaffolds with the CgECM-cartilage phase in green and the OgECM-bone phase in red-brown. d Stress-strain curves for each layer of the GO-COL scaffolds. e Cross-sectional SEM of the cartilage and bone phase scaffolds106,122. Adapted from Mou et al., Copyright 2024 Elsevier B.V. License Number: 6194351502158.Table 1Comparative summary of graphene-based material scaffold systems discussed in Sections 3.3 and 3.4: matrix/scaffold type, graphene derivative, loading concentration, fabrication method, and principal mechanical and biological outcomesMatrix/scaffold typeGraphene derivativeConcentrationFabrication methodKey mechanical/biological outcomeRefs.Section 3.3 — Synthetic polymer and hydrogel compositesPVA/PEG hydrogelGOConcentration-dependent (specific wt% not reported)Freeze–thaw + annealing (freeze-drying)≈200% higher tensile strength, + 40% elongation at break, + 100% compressive modulus vs PVA–PEG control; attributed to uniform GO dispersion and GO–PVA hydrogen bonding116PVA–polyacrylic acid (PAA) hydrogelGONot reported numericallyCrosslinked hydrogel1.5× tensile strength, 1.35× elastic modulus; compressive strength within physiological range of native AC; withstood 500,000 friction cycles117Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV)GO0.5–2.0 wt% (optimal 1.5 wt%)Electrospinning (nanofibrous)1.5 wt% GO → tensile strength 2.08 ± 0.33 MPa vs 0.59 ± 0.12 MPa control; enhanced piezoelectric coefficient; strength declined > 1.5 wt% due to GO aggregation118Gellan gum (GG) / PEGDA bilayer (zonal AC-mimetic)GO0.01% (w/v) in superficial GG layerBilayer casting / photocrosslinkingElastic modulus unchanged; fracture stress 194 ± 27 → 246 ± 34 kPa; zonal integrity over 100,000 friction cycles; lower COF 0.018 ± 0.004 vs 0.025 ± 0.003 (synthetic synovial fluid)107Section 3.4 — Natural and ECM-derived scaffoldsChitosan filmGO and rGO (multiple reduction routes)Not reported numericallySolvent casting (films)GO → +35% Young’s modulus vs pure chitosan; rGO (grape/tea extract) → decreased modulus; rGO (L-ascorbic acid) → ↑crystallinity, greater flexibility, reduced brittleness, lowest overall modulus120Acellular cartilage ECM (ACM) scaffoldGOUp to 6 mg/mLFreeze-dryingCompressive elastic modulus ↑ with GO; 6 mg/mL → 0.217 ± 0.007 MPa (≈5× control 0.043 ± 0.002 MPa); porosity preserved; more uniform interconnected pores; ↑thermal stability (in vitro + in vivo)106GO–collagen (GO-COL) / nHAP bilayer, ECM-coatedGOCartilage layer 0.05 wt% GO; bone layer 0.2 wt% GOFreeze-drying (bilayer) + CgECM/OgECM coatingBone-layer Young’s modulus 0.979 ± 0.132 MPa vs cartilage-layer 0.199 ± 0.059 MPa; matrix composition and GO content tuned to zonal osteochondral requirements122AC articular cartilage, COF coefficient of friction, ECM extracellular matrix, GO graphene oxide, rGO reduced graphene oxide, PVA poly(vinyl alcohol), PEG poly(ethylene glycol), PEGDA poly(ethylene glycol) diacrylate, nHAP nano-hydroxyapatite. GO incorporation into ECM-based scaffolds. a SEM imaging of ACM and GO scaffolds before (-) and after (+) crosslinking at i & vi) 0 mg/mL, ii & vii) 1 mg/mL, iii & viii) 2 mg/mL, iv & ix) 4 mg/mL, and v & x) 4 mg/mL concentrations. Adapted from Gong et al., Copyright 2020 Elsevier B.V. 2020. License Number: 6194351389673. b Schematic diagram of biphasic CgECM and OgECM scaffolds. c Macroscopic view of the assembled biphasic ECM scaffolds with the CgECM-cartilage phase in green and the OgECM-bone phase in red-brown. d Stress-strain curves for each layer of the GO-COL scaffolds. e Cross-sectional SEM of the cartilage and bone phase scaffolds106,122. Adapted from Mou et al., Copyright 2024 Elsevier B.V. License Number: 6194351502158. Table 1Comparative summary of graphene-based material scaffold systems discussed in Sections 3.3 and 3.4: matrix/scaffold type, graphene derivative, loading concentration, fabrication method, and principal mechanical and biological outcomesMatrix/scaffold typeGraphene derivativeConcentrationFabrication methodKey mechanical/biological outcomeRefs.Section 3.3 — Synthetic polymer and hydrogel compositesPVA/PEG hydrogelGOConcentration-dependent (specific wt% not reported)Freeze–thaw + annealing (freeze-drying)≈200% higher tensile strength, + 40% elongation at break, + 100% compressive modulus vs PVA–PEG control; attributed to uniform GO dispersion and GO–PVA hydrogen bonding116PVA–polyacrylic acid (PAA) hydrogelGONot reported numericallyCrosslinked hydrogel1.5× tensile strength, 1.35× elastic modulus; compressive strength within physiological range of native AC; withstood 500,000 friction cycles117Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV)GO0.5–2.0 wt% (optimal 1.5 wt%)Electrospinning (nanofibrous)1.5 wt% GO → tensile strength 2.08 ± 0.33 MPa vs 0.59 ± 0.12 MPa control; enhanced piezoelectric coefficient; strength declined > 1.5 wt% due to GO aggregation118Gellan gum (GG) / PEGDA bilayer (zonal AC-mimetic)GO0.01% (w/v) in superficial GG layerBilayer casting / photocrosslinkingElastic modulus unchanged; fracture stress 194 ± 27 → 246 ± 34 kPa; zonal integrity over 100,000 friction cycles; lower COF 0.018 ± 0.004 vs 0.025 ± 0.003 (synthetic synovial fluid)107Section 3.4 — Natural and ECM-derived scaffoldsChitosan filmGO and rGO (multiple reduction routes)Not reported numericallySolvent casting (films)GO → +35% Young’s modulus vs pure chitosan; rGO (grape/tea extract) → decreased modulus; rGO (L-ascorbic acid) → ↑crystallinity, greater flexibility, reduced brittleness, lowest overall modulus120Acellular cartilage ECM (ACM) scaffoldGOUp to 6 mg/mLFreeze-dryingCompressive elastic modulus ↑ with GO; 6 mg/mL → 0.217 ± 0.007 MPa (≈5× control 0.043 ± 0.002 MPa); porosity preserved; more uniform interconnected pores; ↑thermal stability (in vitro + in vivo)106GO–collagen (GO-COL) / nHAP bilayer, ECM-coatedGOCartilage layer 0.05 wt% GO; bone layer 0.2 wt% GOFreeze-drying (bilayer) + CgECM/OgECM coatingBone-layer Young’s modulus 0.979 ± 0.132 MPa vs cartilage-layer 0.199 ± 0.059 MPa; matrix composition and GO content tuned to zonal osteochondral requirements122AC articular cartilage, COF coefficient of friction, ECM extracellular matrix, GO graphene oxide, rGO reduced graphene oxide, PVA poly(vinyl alcohol), PEG poly(ethylene glycol), PEGDA poly(ethylene glycol) diacrylate, nHAP nano-hydroxyapatite. Comparative summary of graphene-based material scaffold systems discussed in Sections 3.3 and 3.4: matrix/scaffold type, graphene derivative, loading concentration, fabrication method, and principal mechanical and biological outcomes AC articular cartilage, COF coefficient of friction, ECM extracellular matrix, GO graphene oxide, rGO reduced graphene oxide, PVA poly(vinyl alcohol), PEG poly(ethylene glycol), PEGDA poly(ethylene glycol) diacrylate, nHAP nano-hydroxyapatite. Regulation of Chondrogenesis: Signaling Pathways and Stimulus Methods While mechanical reinforcement remains a key motivation for incorporating graphene into scaffold systems, many studies also report changes in cellular behavior, matrix deposition, and gene expression123. These effects suggest that graphene materials modulate cellular behavior through a combination of biophysical, biochemical, and electroactive mechanisms. In cartilage TE, these effects are particularly relevant given the sensitivity of chondrocytes and stem cells to changes in substrate stiffness, topography, surface chemistry, and electrical cues124,125. In practice, researchers attempt to activate signaling pathways through mechanical loading, biochemical supplementation, electrical stimulation, and modulation of the physical environment to direct chondrocyte or stem cell signaling. These targeted stimuli are designed to engage mechanotransductive, electroresponsive, and matrix-regulated signaling cascades that drive differentiation and matrix assembly during engineered cartilage formation. However, the mechanisms by which graphene-derivative-based scaffolds influence cell behavior remain incompletely understood. Signaling Pathways in Cartilage Tissue Engineering Research demonstrates that chondrogenesis is a multistage process involving mesenchymal condensation, proliferation, matrix deposition, and hypertrophic maturation (Fig. 7)126. Each stage is governed by a complex network of signaling pathways that integrate growth factor stimulation, cell-matrix interactions, mechanical cues, and intracellular feedback to regulate differentiation and phenotypic stability127,128. Key pathways implicated in chondrocyte regulation include transforming growth factor beta (TGF-β)/bone morphogenic protein (BMP), Wnt (canonical and non-canonical), Indian Hedgehog (Ihh)/parathyroid hormone-related protein (PTHrP), mitogen-activated protein kinase (MAPK), and Notch. Their roles in response to graphene-based scaffolds remain poorly defined and are likely influenced by scaffold stiffness, surface chemistry, and co-stimulatory signals.Fig. 7Signaling pathways and proteins involved in chondrogenic differentiation of mesenchymal stem cells.R-SMAD-dependent TGF-β and Hedgehog pathways can promote the overexpression of Sox9, whereas Notch and Wnt pathways can inhibit chondrogenic transcription factor Sox9. FGF can act on R-SMAD-independent TGF-β pathway, thus playing a part in chondrogenic differentiation. There are other molecules that interact with Sox9, such as osteogenic transcription factor Runx2, peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PGC1-α) and the member of histone acetyltransferase family P300/CBP128. Adapted from Yang et al., under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0). Signaling pathways and proteins involved in chondrogenic differentiation of mesenchymal stem cells. R-SMAD-dependent TGF-β and Hedgehog pathways can promote the overexpression of Sox9, whereas Notch and Wnt pathways can inhibit chondrogenic transcription factor Sox9. FGF can act on R-SMAD-independent TGF-β pathway, thus playing a part in chondrogenic differentiation. There are other molecules that interact with Sox9, such as osteogenic transcription factor Runx2, peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PGC1-α) and the member of histone acetyltransferase family P300/CBP128. Adapted from Yang et al., under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0). The TGF-β/BMP signaling axis is central to early chondrogenic commitment129,130. TGF-β1 and TGF-β3 activate serine/threonine receptors that phosphorylate SMAD2/3 proteins, which complex with SMAD4 and translocate to the nucleus to upregulate chondrogenic genes such as SRY-box transcription factor 9 (SOX9), type II collagen (COL2A1), and aggrecan (ACAN)131. The BMP sub-branch of the TGF-β superfamily, particularly BMP-2/4/7, signals through SMAD1/5/8 and promotes similar chondrogenic outcomes, especially during early mesenchymal condensation and matrix production132–137. While BMPs enhance the expression of SOX9, SOX5, and SOX6, they can accelerate hypertrophy when not counterbalanced by TGF-β signaling133,135. Wnt signaling plays dual and stage-dependent roles in chondrogenesis. Canonical Wnt ligands activate β-catenin signaling, which inhibits early chondrogenesis while promoting hypertrophy and ossification138,139. Wnt antagonists have been shown to preserve chondrogenic potential by preventing premature differentiation. In contrast, non-canonical Wnt ligands have been shown to regulate planar cell polarity (PCP) and cytoskeletal organization, supporting columnar alignment in growth plate chondrocytes140. Balanced activation of both pathways is necessary for cartilage homeostasis but is often disrupted in OA-like models or mechanically overstimulated environments141. The Ihh/PTHrP feedback loop regulates the transition from proliferation to hypertrophy during endochondral ossification142. Ihh, secreted by pre-hypertrophic chondrocytes, induces PTHrP expression in the periarticular region. PTHrP then diffuses back to maintain proliferating chondrocytes in an undifferentiated, matrix-producing state. Ihh interacting with PTHrP promotes elongation of the forming tissue, and then chondrocytes move beyond the PTHrP gradient, allowing hypertrophy to proceed. This spatially regulated loop ensures a steady progression through the chondrogenic cell cycle and may be particularly relevant for engineered systems attempting to recreate zonal cartilage architecture143. The MAPK family, including extracellular signal-regulated kinase 1/2 (ERK1/ERK2), c-Jun N-terminal kinase (JNK), and p38 MAPK, is frequently activated in response to mechanical, inflammatory, and biochemical cues144. These kinases can enhance or suppress SOX9 activity depending on the duration and magnitude of stimulation145. Importantly, MAPK pathways also modulate the activity of SMAD proteins through phosphorylation at non-canonical sites, allowing for crosstalk between mechanical and biochemical signaling axes146,147. Notch signaling regulates chondrogenesis by suppressing terminal differentiation148. When the Notch receptor is activated, it releases the Notch intracellular domain (NICD), which enters the nucleus, binds to transcription factors, and converts them from repressors into activators. This interaction induces expression of transcriptional repressors that interfere with chondrogenic gene expression. Specifically, HES-1 and HEY-1 inhibit the activity of SOX9 at the COL2A1 enhancer region, blocking cartilage matrix gene transcription and delaying chondrocyte maturation149. As a result, overactivation of Notch signaling can restrict chondrogenic differentiation during developmental or inflammatory contexts. While Notch activity is often elevated in OA cartilage, its suppression may help maintain stable chondrogenic phenotypes150. Bioreactor Technologies for Mechanical, Electrical, and Biochemical Modulation The signaling pathways summarized in Table 2 illustrate how biochemical, mechanical, and electrical cues can influence chondrogenic differentiation. Leveraging these biological mechanisms requires specialized bioreactors and carefully designed scaffolds. The following subsections address these stimulation strategies in detail, highlighting bioreactor technologies, scaffold design considerations, and hardware that enable precise control of cues to engineered cartilage systems.Table 2Key signaling pathways regulating chondrogenesis, their biological roles, activation in tissue-engineering contexts, and stimulation techniques that modulate their activityPathwayStage(s) of ChondrogenesisActivation in Tissue Engineering – Stimulation TechniquesRefs.TGF-β/BMPCondensation &differentiation: Potent inducer of MSC chondrogenic commitment and early cartilage matrix productionHypertrophy: TGF-β signaling inhibits terminal maturation of chondrocytesBiochemical: TGF-β is widely used to induce MSC chondrogenesis; BMP-2/7 gene-loaded scaffolds further boost cartilage matrix deposition128,185–187Mechanical: Dynamic compression releases latent TGF-β from the ECM and upregulates its transcriptionElectrical: ES elevates TGF-β1 expression and BMP-2; BMP inhibition nullifies ES-induced COL2A1, ACAN, and SOX9 up-regulation, while condensation still occurs.Wnt/β-Catenin(Canonical Wnt)Differentiation: Wnt/β-catenin signaling drives progenitors toward osteoblast lineage and suppresses chondrogenic differentiationHypertrophy: β-catenin activation accelerates chondrocyte maturation, while its inactivation allows prolonged SOX9 expressionBiochemical: Wnt pathway inhibitors are used to enhance chondrogenesis and prevent hypertrophy.188–190Mechanical: Static load can induce β-catenin activation in chondrocytes; in TE a soft matrix is preferred to keep β-catenin signaling low.Electrical: Nanosecond pulsed electric fields have resulted in enhanced proliferation and dedifferentiation of chondrocytes via the Wnt/β-catenin pathwayNon-Canonical Wnt Planar Cell Polarity (PCP)Morphogenesis & organization: Regulates tissue architecture, columnar stacking of growth plate chondrocytesBiochemical: Delivery of Wnt5a or Wnt11 proteins in scaffolds has been shown to synergize with TGF-β to promote chondrogenic gene expression189,191–193Mechanical: Wnt/PCP signaling is influenced by shear and dynamic compressionIhh/PTHrP feedback loopProliferation: Ihh is secreted by pre-hypertrophic chondrocytes and signals to stimulate proliferationOssification transition: Ihh induces osteoblast development in the perichondriumBiochemical: Ihh gene transfer to MSCs has shown chondrogenic induction; Coculturing MSCs with hypertrophic chondrocytes or osteoblasts (sources of Ihh) can elevate Ihh in developing constructs194–196Mechanical: The primary cilium is required for Hedgehog transduction, thus mechanical stimuli that bend cilia might module Ihh signaling indirectlyNotchEarly commitment: Notch signaling inhibits chondrogenic differentiation in MSCsBiochemical: Notch pathway inhibitors are used during MSC expansion to preserve chondrogenic potential; high-density culture naturally elevates Notch, so seeding density is tuned in TE to avoid excessive Notch signaling197,198Mechanical: Dynamic mechanical loading resulted in significant upregulation of the Notch pathway in ex vivo studiesFibroblast growth factor (FGF)Expansion & early differentiation: FGF’s regulate chondrocyte proliferation and the timing of hypertrophyBiochemical: FGF-2 is commonly used during MSC expansion (2D) to maintain proliferative capacity before chondrogenic induction. FGF-18 (3D) has been tested to stimulate cartilage ECM and has entered clinical trials for OA (sprifermin)126,199–202Insulin-like growth factor (IGF)Matrix anabolism & survival: IFG-1 promotes chondrocyte and MSC proliferation and extracellular matrix synthesis and reduces apoptosisBiochemical: IGF-1 is frequently added to chondrogenic media to enhance GAGs and COL2A1 accumulation203–205Mechanical: IGF-1 has been shown to regulate chondrocyte mechanosensitivity Dynamic compressive of cartilage constructs increases IGF-1 expression, which contributes to load-induced matrix assembly.Electrical: Bipolar pulse stimulation has been shown to increase the secretion if IGFBP2/3 Table 2Key signaling pathways regulating chondrogenesis, their biological roles, activation in tissue-engineering contexts, and stimulation techniques that modulate their activityPathwayStage(s) of ChondrogenesisActivation in Tissue Engineering – Stimulation TechniquesRefs.TGF-β/BMPCondensation &differentiation: Potent inducer of MSC chondrogenic commitment and early cartilage matrix productionHypertrophy: TGF-β signaling inhibits terminal maturation of chondrocytesBiochemical: TGF-β is widely used to induce MSC chondrogenesis; BMP-2/7 gene-loaded scaffolds further boost cartilage matrix deposition128,185–187Mechanical: Dynamic compression releases latent TGF-β from the ECM and upregulates its transcriptionElectrical: ES elevates TGF-β1 expression and BMP-2; BMP inhibition nullifies ES-induced COL2A1, ACAN, and SOX9 up-regulation, while condensation still occurs.Wnt/β-Catenin(Canonical Wnt)Differentiation: Wnt/β-catenin signaling drives progenitors toward osteoblast lineage and suppresses chondrogenic differentiationHypertrophy: β-catenin activation accelerates chondrocyte maturation, while its inactivation allows prolonged SOX9 expressionBiochemical: Wnt pathway inhibitors are used to enhance chondrogenesis and prevent hypertrophy.188–190Mechanical: Static load can induce β-catenin activation in chondrocytes; in TE a soft matrix is preferred to keep β-catenin signaling low.Electrical: Nanosecond pulsed electric fields have resulted in enhanced proliferation and dedifferentiation of chondrocytes via the Wnt/β-catenin pathwayNon-Canonical Wnt Planar Cell Polarity (PCP)Morphogenesis & organization: Regulates tissue architecture, columnar stacking of growth plate chondrocytesBiochemical: Delivery of Wnt5a or Wnt11 proteins in scaffolds has been shown to synergize with TGF-β to promote chondrogenic gene expression189,191–193Mechanical: Wnt/PCP signaling is influenced by shear and dynamic compressionIhh/PTHrP feedback loopProliferation: Ihh is secreted by pre-hypertrophic chondrocytes and signals to stimulate proliferationOssification transition: Ihh induces osteoblast development in the perichondriumBiochemical: Ihh gene transfer to MSCs has shown chondrogenic induction; Coculturing MSCs with hypertrophic chondrocytes or osteoblasts (sources of Ihh) can elevate Ihh in developing constructs194–196Mechanical: The primary cilium is required for Hedgehog transduction, thus mechanical stimuli that bend cilia might module Ihh signaling indirectlyNotchEarly commitment: Notch signaling inhibits chondrogenic differentiation in MSCsBiochemical: Notch pathway inhibitors are used during MSC expansion to preserve chondrogenic potential; high-density culture naturally elevates Notch, so seeding density is tuned in TE to avoid excessive Notch signaling197,198Mechanical: Dynamic mechanical loading resulted in significant upregulation of the Notch pathway in ex vivo studiesFibroblast growth factor (FGF)Expansion & early differentiation: FGF’s regulate chondrocyte proliferation and the timing of hypertrophyBiochemical: FGF-2 is commonly used during MSC expansion (2D) to maintain proliferative capacity before chondrogenic induction. FGF-18 (3D) has been tested to stimulate cartilage ECM and has entered clinical trials for OA (sprifermin)126,199–202Insulin-like growth factor (IGF)Matrix anabolism & survival: IFG-1 promotes chondrocyte and MSC proliferation and extracellular matrix synthesis and reduces apoptosisBiochemical: IGF-1 is frequently added to chondrogenic media to enhance GAGs and COL2A1 accumulation203–205Mechanical: IGF-1 has been shown to regulate chondrocyte mechanosensitivity Dynamic compressive of cartilage constructs increases IGF-1 expression, which contributes to load-induced matrix assembly.Electrical: Bipolar pulse stimulation has been shown to increase the secretion if IGFBP2/3 Key signaling pathways regulating chondrogenesis, their biological roles, activation in tissue-engineering contexts, and stimulation techniques that modulate their activity Condensation & differentiation: Potent inducer of MSC chondrogenic commitment and early cartilage matrix production Hypertrophy: TGF-β signaling inhibits terminal maturation of chondrocytes Wnt/β-Catenin (Canonical Wnt) Differentiation: Wnt/β-catenin signaling drives progenitors toward osteoblast lineage and suppresses chondrogenic differentiation Hypertrophy: β-catenin activation accelerates chondrocyte maturation, while its inactivation allows prolonged SOX9 expression Proliferation: Ihh is secreted by pre-hypertrophic chondrocytes and signals to stimulate proliferation Ossification transition: Ihh induces osteoblast development in the perichondrium Biochemical Stimulation: Growth Factors and Signaling Molecules A common method for initiating chondrogenesis in vitro involves supplementation with insulin, transferrin, and selenium (ITS), which supports cell viability, metabolic activity, and early matrix synthesis under serum-free conditions. Insulin promotes anabolic processes and enhances the production of cartilage-specific proteins such as collagen type II and aggrecan. Transferrin facilitates iron transport and supports redox homeostasis, while selenium serves as a cofactor for antioxidant enzymes, reducing oxidative stress during differentiation. Although ITS alone can promote early chondrogenic commitment, it is typically used as a basal supplement in combination with other potent biochemical cues151,152. Biochemical stimulation leverages growth factors and cytokines to drive chondrogenic differentiation and matrix synthesis, mimicking native morphogen gradients153. In vitro, this often involves supplementing media with TGF-β1/3, BMP-2/7, IGF-1, or FGF-2 – factors known to induce chondrogenic gene expression and ECM assembly154–159. TGF-β1 drives ACAN and COL2A1 expression; BMPs enhance matrix formation but risk hypertrophic drift129. IGF-1 promotes anabolic activity, while FGF-2 supports progenitor cell proliferation and primes cells for differentiation160. Controlled delivery strategies, such as encapsulation in microspheres or tethering to scaffold matrices, can improve factor stability and spatial precision161,162. However, biochemical cues alone often result in constructs with poor mechanical resilience or phenotypic stability. Rapid degradation of growth factors, high cost, and uneven distribution in 3D cultures remain key challenges. As such, systems should incorporate co-stimulation with mechanical or electrical inputs in bioreactor platforms to better replicate the complex signaling environment of native cartilage. Mechanical Stimulation: Dynamic Loading and Physiological Forces In vivo, chondrocytes are exposed to dynamic compressive, tensile, and fluid-induced forces that regulate tissue structure and function163. These mechanical cues are transduced through integrins, mechanosensitive ion channels, and cytoskeletal linkages, initiating intracellular signaling cascades that regulate proliferation, phenotype stability, and ECM production164. In engineered systems, the absence of mechanical input often results in fibrocartilage-like tissue165. To address this, mechanical stimulation is applied in vitro to improve ECM deposition and functional properties. For example, dynamic compression at <10% strain enhances cell viability, collagen and GAG protein expression, and mechanical properties such as equilibrium and aggregate moduli. Similarly, hydrostatic pressure up to 10 MPa promotes GAG accumulation without damaging scaffold architecture166. Bioreactors deliver these stimuli through compression platens, sealed pressure vessels, perfusion systems, and tension rigs (Fig. 8)167. Despite their utility, most systems remain low-throughput, labor-intensive, and are prone to operator variability. The inconsistencies in stimulation parameters across studies, non-uniform strain fields in 3D constructs, and difficulty integrating multimodal or sequential stimuli remain persistent challenges that hinder standardization and scalability.Fig. 8Common bioreactors used in cartilage tissue engineering.a 3-neck spinner flask bioreactor (1) where scaffolds (2) are subjected to stirring via stir bar (3) while attached to a needle (4) in cell suspension (5). b Compression bioreactor applying unconfined loading through an actuator. c Flow perfusion bioreactor where media is forced through the scaffold in the scaffold chamber by syringe pump. d Rotating wall vessel bioreactor where scaffolds are suspended in medium due to opposing gravitational and drag forces. a, c, d Adapted from Partap et al., under the terms of the Attribution-Noncommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0)167. Common bioreactors used in cartilage tissue engineering. a 3-neck spinner flask bioreactor (1) where scaffolds (2) are subjected to stirring via stir bar (3) while attached to a needle (4) in cell suspension (5). b Compression bioreactor applying unconfined loading through an actuator. c Flow perfusion bioreactor where media is forced through the scaffold in the scaffold chamber by syringe pump. d Rotating wall vessel bioreactor where scaffolds are suspended in medium due to opposing gravitational and drag forces. a, c, d Adapted from Partap et al., under the terms of the Attribution-Noncommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0)167. Electrical Stimulation: Techniques, Challenges, and Cellular Outcomes ES delivered through bioreactors has shown promise in promoting chondrogenic differentiation and enhancing ECM production168. Two primary modalities are used: capacitive coupling, which uses external electrodes to generate an electric field across the culture, and direct coupling, where electrodes are in direct contact with ionic media (Fig. 9)153. Both methods can modulate cell proliferation, condensation, and matrix synthesis, often via voltage-gated calcium (Ca2+) channels and downstream pathways169. However, field dissipation, high media resistance, scaffold resistivity, and spatial inhomogeneity complicate application (Fig. 10). Inconsistent reporting of parameters like voltage, frequency, and waveform further hinders efforts to link quantitative field strength with biological outcomes. Field dissipation due to electrode spacing, thermal effects, and scaffold conductivity can impact the magnitude and spatial uniformity of applied fields. While 2D monolayer studies have demonstrated that ES can drive chondrogenic differentiation and matrix deposition, translating these findings to 3D constructs remain difficult168.Fig. 9Common electrical stimulus methods for cell culture.Two common methods to deliver electrical stimulation to cells in vitro: (a) direct coupling is cell culture media and (b) capacitive coupling. Figure created with Biorender.com.Fig. 10Alluvial diagram illustrating the diverse effects of electrical stimulus parameters on cellular responses in cartilage tissue engineering applications.The diagram visualizes the relationship among the coupling method, electric field strength, frequency, and observed cellular behavior across 16 studies. Studies utilizing 3D bioscaffolds are denoted by an open star, highlighting their role in specific coupling conditions. The diagram emphasizes the variability in electrical stimulus protocols and their impact on cellular processes, including proliferation, differentiation, condensation, ECM synthesis, and cell viability. Adapted from Sawyer et al., under the terms of the Attribution-Non Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0)182. Common electrical stimulus methods for cell culture. Two common methods to deliver electrical stimulation to cells in vitro: (a) direct coupling is cell culture media and (b) capacitive coupling. Figure created with Biorender.com. Alluvial diagram illustrating the diverse effects of electrical stimulus parameters on cellular responses in cartilage tissue engineering applications. The diagram visualizes the relationship among the coupling method, electric field strength, frequency, and observed cellular behavior across 16 studies. Studies utilizing 3D bioscaffolds are denoted by an open star, highlighting their role in specific coupling conditions. The diagram emphasizes the variability in electrical stimulus protocols and their impact on cellular processes, including proliferation, differentiation, condensation, ECM synthesis, and cell viability. Adapted from Sawyer et al., under the terms of the Attribution-Non Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0)182. Mechanisms of graphene-cell interactions in cartilage tissue engineering While bioreactor platforms deliver biochemical, mechanical, and electrical inputs, the scaffold material serves as the primary interface for signal transduction. Graphene-based materials – due to their unique combination of stiffness, topography, surface chemistry, and conductivity – offer unprecedented opportunities to modulate cell behavior. Importantly, each graphene derivative (e.g., GO, rGO, pristine graphene) presents distinct physiochemical features that govern cellular response170. This section reviews current understanding of graphene-cell interactions, focusing on how graphene’s mechanical and surface properties influence intracellular pathways, how its chemistry modulates protein and growth factor dynamics, and how its conductivity may be leveraged for scaffold-coupled electrical stimulation in cartilage TE. Mechanotransduction and matrix-cell signaling via graphene scaffold properties Graphene-based materials bioscaffolds introduce biophysical cues that can engage mechanosensitive pathways in chondrogenic cells36. Several studies report that graphene-derivative substrates promote stem cell differentiation without exogenous growth factors, a finding interpreted as evidence of intrinsic bioactivity. Because the mechanisms underlying these effects are multifactorial and, in most cartilage-relevant systems, remain incompletely resolved, we distinguish throughout this section between outcomes that were directly measured and mechanisms that were proposed by the original authors or inferred from related literature (Fig. 11).Fig. 11The physical and chemical properties of graphene derivatives affect the environment and cellular behavior to modulate cell response toward differentiation.a Graphene derivatives interact with hormones, growth factors, and other biomolecules by different chemical interactions (e.g., electrostatic, π-π bonds, hydrogen bonding, hydrophobic interactions), enhancing the local bioavailability of such compounds and consequently increasing cell differentiation. b The contact of the cell membrane to GFN triggers intracellular cascades that can modulate cell response. c Surface topography promotes cell anchorage and triggers mechanosensitive pathways that have been linked to osteogenic differentiation. d Graphene has remarkable electrical properties, which have been linked to increased neuron activity. These properties may also be related to the increased neurite growth observed on graphene36. Adapted from Luong-Van et al., Copyright 2020 Elsevier. License Number: 6194361282941. The physical and chemical properties of graphene derivatives affect the environment and cellular behavior to modulate cell response toward differentiation. a Graphene derivatives interact with hormones, growth factors, and other biomolecules by different chemical interactions (e.g., electrostatic, π-π bonds, hydrogen bonding, hydrophobic interactions), enhancing the local bioavailability of such compounds and consequently increasing cell differentiation. b The contact of the cell membrane to GFN triggers intracellular cascades that can modulate cell response. c Surface topography promotes cell anchorage and triggers mechanosensitive pathways that have been linked to osteogenic differentiation. d Graphene has remarkable electrical properties, which have been linked to increased neuron activity. These properties may also be related to the increased neurite growth observed on graphene36. Adapted from Luong-Van et al., Copyright 2020 Elsevier. License Number: 6194361282941. The tunable stiffness and nanoscale roughness of graphene derivatives such as GO can alter focal-adhesion dynamics and cytoskeletal tension in adherent cells. Alginate hydrogels functionalized with 2 wt% GO nanosheets were directly measured and exhibited a six-fold increase in compressive modulus, enhanced human mesenchymal stem cell (hMSC) viability through day 10, and promoted chondrogenic differentiation by day 21, as confirmed by Safranin O and Alcian Blue staining171. The authors did not dissect intracellular signaling; a plausible explanation, extrapolated from other systems, is that increased matrix stiffness enhanced integrin engagement and downstream focal adhesion kinase (FAK) activation, processes known to promote proliferation and chondrogenesis172,173. This pathway was not directly tested in the study (e.g., no FAK inhibition, knockdown, or phosphorylation readout), and it is presented here as a hypothesis rather than an established conclusion. The strongest direct evidence for active mechanotransduction comes from Ogene et al. 174. Direct measurements of GO exposure showed increased plasma membrane tension in 3D chondrocyte pellets, quantified by fluorescence lifetime imaging (FLIM), that depended on GO flake size and concentration. This was accompanied by activation of latent TGF-β and downstream TGF-β signaling, increased YAP/TAZ transcriptional activity, and upregulation of the mechanosensitive ion channels PIEZO1 and TRPV4, both responsive to membrane deformation and osmotic stress in chondrocytes (Fig. 12)174. These are directly quantified imaging and gene-expression outcomes. Together, these measurements support the conclusion that graphene-based materials provide not only passive mechanical support but also actively engage mechanoresponsive signaling.Fig. 12Ultrasmall GO (us-GO) increases plasma membrane stiffness and activates mechanosensory pathways.a Fluorescent lifetime imaging (FLIM) analysis of plasma membrane stiffness in untreated, us-GO (5 μg ml−1) treated- and TGFβ-3 (10 ng ml−1) treated-cells after 4 h. Images were taken using a Leica SP8 Inverted 3D FLIM confocal microscope using a 40× objective and analyzed using LASX FLIM software version 3.56. Scale bar represents 50 μm. White arrows indicate examples of ROIs used to calculate lifetimes. b Quantification of lifetime analysis. Each data point represents lifetime (ns) generated from 10 ROIs per image. Values in us-GO group were subtracted by measuring (negligible) background lifetime (0.048 ns) from GO autofluorescence. c Analysis of active YAP/TAZ activity via TEAD induction 4 h after stimulation with us-GO (5 μg ml−1) or 10 ng ml−1 TGFβ. d Gene expression analysis of PIEZO1, TRPV4 and ADAMTSL2 24 hours after treatment with us-GO. Gene expression was normalized to GAPDH. Results are presented as fold increase in gene expression normalized to untreated cells (*p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.0001)174. Adapted from Ogene et al., under the terms of the Attribution 3.0 Unported (CC BY 3.0). Ultrasmall GO (us-GO) increases plasma membrane stiffness and activates mechanosensory pathways. a Fluorescent lifetime imaging (FLIM) analysis of plasma membrane stiffness in untreated, us-GO (5 μg ml−1) treated- and TGFβ-3 (10 ng ml−1) treated-cells after 4 h. Images were taken using a Leica SP8 Inverted 3D FLIM confocal microscope using a 40× objective and analyzed using LASX FLIM software version 3.56. Scale bar represents 50 μm. White arrows indicate examples of ROIs used to calculate lifetimes. b Quantification of lifetime analysis. Each data point represents lifetime (ns) generated from 10 ROIs per image. Values in us-GO group were subtracted by measuring (negligible) background lifetime (0.048 ns) from GO autofluorescence. c Analysis of active YAP/TAZ activity via TEAD induction 4 h after stimulation with us-GO (5 μg ml−1) or 10 ng ml−1 TGFβ. d Gene expression analysis of PIEZO1, TRPV4 and ADAMTSL2 24 hours after treatment with us-GO. Gene expression was normalized to GAPDH. Results are presented as fold increase in gene expression normalized to untreated cells (*p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.0001)174. Adapted from Ogene et al., under the terms of the Attribution 3.0 Unported (CC BY 3.0). Gong et al. directly measured GO incorporated into 3D acellular cartilage matrix (ACM) scaffolds and cultured bone-marrow mesenchymal stem cells (BMSCs) under chondrogenic conditions106. GO-modified scaffolds (2 mg/mL) significantly increased SOX9, ACAN, and COL2A1 expression at days 3 and 7 relative to unmodified controls. The stiffening effect of GO likely contributed, but the authors noted that the magnitude and speed of the transcriptional changes are also consistent with GO interacting with cell-surface receptors or modulating intracellular signaling cascades through additional pathways. This receptor/signaling hypothesis was not directly interrogated and remains speculative. Taken together, these studies indicate that graphene-derivative scaffolds can influence chondrogenic phenotype through several routes. Of these, membrane-tension–driven ion-channel and YAP/TAZ engagement is directly supported by experimental data (Ogene et al.)174, whereas stiffness-driven integrin/FAK signaling and direct GO–receptor interactions remain plausible but experimentally unconfirmed in cartilage-relevant systems. As emphasized in Section 5, closing this gap will require functional validation, such as pathway inhibition, knockdown, or reporter systems, to separate graphene-specific effects from generic responses to stiffness, charge, or nanoscale topography. Mechanotransduction is, moreover, only one facet of graphene-based materials’ bioactivity: the high surface area, abundant functional groups, and conjugated domains of graphene derivatives also drive strong interactions with biomolecules, supporting protein adsorption, growth-factor retention, and localized biochemical signaling, as examined in the next section. Graphene as a Bioactive Platform for Protein Adsorption and Growth Factor Delivery Graphene derivatives support the bioactive molecules’ adsorption, stabilization, and delivery, which are driven by noncovalent van der Waals, electrostatic, hydrophobic, π-π stacking, and hydrogen bonding forces175,176. These surface interactions are governed by the physiochemical properties of the graphene surface – including oxidation level, surface charge, and π-conjugation – which influence both protein binding capacity and conformational stability36. For example, the binding of bovine serum albumin to GO has been shown to scale with the oxidative state, with higher oxygen content increasing electrostatic and hydrogen-bonding interactions and promoting stable adsorption177. When Lee et al. compared the binding behavior of insulin on pristine graphene and GO surfaces, it was found that insulin denatured on pristine graphene due to dominant π-π stacking disrupting its tertiary structure178. In contrast, GO’s additional capacity for hydrogen bonding and electrostatic interactions preserved insulin’s 3D conformation, nearly doubling its binding efficiency relative to pristine graphene (Fig. 13). These findings suggest that GO not only improves biomolecule retention but also preserves protein structure and function.Fig. 13Interaction of insulin with graphene and GO surfaces.a Loading capacity of insulin on PDMS, pristine graphene film, and GO at day 1 and 3. b Schematic illustration of insulin adsorption on graphene film (top panel) and GO (bottom panel)178. Adapted from Lee et al., Copyright 2011 American Chemical Society. License Number: 6196710308373. Interaction of insulin with graphene and GO surfaces. a Loading capacity of insulin on PDMS, pristine graphene film, and GO at day 1 and 3. b Schematic illustration of insulin adsorption on graphene film (top panel) and GO (bottom panel)178. Adapted from Lee et al., Copyright 2011 American Chemical Society. License Number: 6196710308373. GO has also been explored as a carrier for delivering both adhesion ligands and growth factors within 3D cultures. A study by Yoon et al. examined GO flakes (~0.5-1 μm) that were pre-loaded with fibronectin and TGF-β3 and incorporated into pellet cultures of human adipose-derived stem cells (hASCs)171. These cultures typically suffer from limited penetration of growth factors, but the protein- and growth factor-loaded GO flakes enhanced both cell adhesion and localized delivery. Cells interacting with the GO and TGF-β3 complex (P-GO-TGF) experienced a controlled release of TGF-β3, which significantly increased phosphorylation of ERK, JNK, and p38 signaling pathways compared to soluble TGF-β3 controls (P-GO + TGF). This corresponded with enhanced expression of SOX9 and ACAN, highlighting the dual function of GO as both a structural and biochemical modulator. Similarly, Pareek et al. investigated arginine-functionalized GO (GO-Arg) as a delivery platform within GO-cellulose nanofiber scaffolds (CNF-GO-Arg)108. GO-Arg particles showed an initial 70% release of arginine within 12 h, followed by a sustained release over 72 h. In the CNF-GO-Arg composite, diffusion through the scaffold matrix prolonged arginine release, resulting in 65% release after 21 days (Fig. 14). This prolonged availability modulated mitochondrial membrane potential and suppressed oxidative stress in hMSCs, leading to improved cell viability, increased proliferation, and enhanced chondrogenic potential as confirmed by Alcian Blue staining. Although cartilage-specific matrix markers were not explicitly reported, the findings suggest that GO-based delivery vehicles may regulate intracellular homeostasis and promote long-term matrix production.Fig. 14CNF-GO-Arg hydrogels facilitate the controlled release of arginine in vitro to promote chondrogenesis.a Schematic representation of facile transport of the released Arginine from CNF-GO-Arg aerogels into the underlying stem cells. b Release kinetics of arginine from GO-Arg flakes and CNF-GO-Arg aerogels. c Digital and brightfield imaging of Alcian blue staining of stem cells cultured in the presence and absence of arginine at day 14. d Alcian blue stain quantification at days 14 and 21108. Adapted from Pareek et al., Copyright 2024 Elsevier B.V. License Number: 6194370725040. CNF-GO-Arg hydrogels facilitate the controlled release of arginine in vitro to promote chondrogenesis. a Schematic representation of facile transport of the released Arginine from CNF-GO-Arg aerogels into the underlying stem cells. b Release kinetics of arginine from GO-Arg flakes and CNF-GO-Arg aerogels. c Digital and brightfield imaging of Alcian blue staining of stem cells cultured in the presence and absence of arginine at day 14. d Alcian blue stain quantification at days 14 and 21108. Adapted from Pareek et al., Copyright 2024 Elsevier B.V. License Number: 6194370725040. Graphene’s protein-binding capabilities, growth factor retention, and modulation of intracellular stress responses make it a compelling bioactive platform for cartilage TE. However, its contributions are not limited to mechanical reinforcement and biochemical delivery. The high electrical conductivity of graphene and its derivatives offers a parallel avenue for enhancing cell behavior through electrical stimulation. The following section examines how graphene can serve as a conduit for scaffold-coupled electrical signals and the role of ES in modulating chondrogenic gene expression, calcium signaling, and matrix synthesis. Graphene-enabled electrical stimulation in cartilage tissue engineering Strain-generated potentials are a well-established mechanism for maintaining AC, in which mechanical forces generate localized electric potentials within the tissue. These endogenous signals are driven by fluid and ionic dynamics such as Donnan equilibrium, diffusion potentials, and inherent piezoelectricity – where the deformation of the ECM itself can generate electrical charges due to anisotropic collagen alignment and fixed charge density within proteoglycans179,180. Chondrocytes sense these bioelectrical cues through voltage-gated ion channels, activating intracellular pathways that regulate transcription, gene expression, and ECM remodeling168. Exogenous ES in cartilage TE aims to mimic these physiologic phenomena. Conventional approaches – such as capacitive coupling or direct electrode contact in ionic media – often suffer from poor field uniformity, limited penetration into 3D constructs, and a lack of real-time feedback on the stimulation microenvironment169. To address these issues, graphene-based materials have emerged as promising electroconductive components for ES-enabled scaffolds. The high conductivity of conductive graphene derivatives (e.g., CVD graphene foam, graphene nanopowder) offers the potential for improved coupling at the scaffold-cell interface. Yet, delivering uniform ES in 3D culture remains a challenge due to the tortuous microarchitecture of porous scaffolds, which can distort field lines and create spatial heterogeneity. Most studies incorporate graphene derivatives (typically graphene nanoplatelets or GO) as a filler within polymeric scaffolds to improve conductivity and mechanical properties, though few directly apply ES to assess functional outcomes163,168. To our knowledge, only the following two studies have directly applied ES to graphene-based scaffolds in cartilage-relevant systems. Deliormanlı et al. investigated scaffolds for osteochondral repair composed of melt-derived 13-93 bioactive glass, poly (ε-Caprolactone) (PCL), and 5 wt% graphene nanopowder (5%G-PCL-B0) seeded with osteoblastic MC3T3-E1 cells, and solvent-cast PCL scaffolds with 10 wt% graphene nanopowder (10%G-PCL) seeded with ATDC5 chondrogenic progenitor cells181. Conductivities of the 5%G-PCL-B0 and 10%G-PCL were 0.074 S/cm and 0.018 S/cm respectively – significantly higher than the controls (PCL-B0: 4.6 × 10−8 S/cm; PCL: 4.7 × 10−7 S/cm) – demonstrating the conductivity enhancement via graphene nanopowder. Scaffolds were seeded and transferred to well plates containing carbon electrodes and immersed in culture media to facilitate direct coupling. A sinusoidal waveform at 20 mV and 60 Hz was applied for 30 minutes/day over three days. Metabolic activity, measured by the MTT assay, showed a significant decrease in MC3T33-E1 cells but a significant increase in ATDC5 cells, highlighting both the influence of cell type and the limitations of scaffold conductivity. More recently, Sawyer et al. applied biphasic square-wave stimuli (20, 40, or 60 mVpp at 1 kHz for 5 min/day over 7 days followed by 7 days of unstimulated growth) directly to CVD-grown GF scaffolds seeded with ATDC5 cells, using custom bioreactors182. This approach led to significant increases in proliferation and improved mechanical properties. The 60 mVpp group exhibited the highest equilibrium modulus and greatest energy dissipation during loading. Critically, this study was the first to link scaffold-coupled ES through a conductive graphene architecture to mechanical performance and cell behavior in a cartilage-specific context. The platform also enabled real-time waveform monitoring and modeled electric-field distribution based on GF tortuosity, which was measured using MicroCT scans of the GF scaffold. The conductivity of the GF was estimated at 1013.7 ± 300.7, 1027.4 ± 287.8, and 997.6 ± 281.1 S/cm for the 20, 40, and 60 mVpp input conditions, respectively, demonstrating consistent bulk electrical performance across stimulation levels with variations well within error– addressing challenges in reproducibility, field localization, and stimulus-to-cell coupling. Low-conductivity scaffolds exhibit high internal resistance, causing most of the applied voltage to drop across the scaffold or bulk media, whereas excessively conductive scaffolds may allow current to bypass cellular interfaces. However, even in highly conductive systems, localized field effects still occur at the nanoscale due to surface charge accumulation and membrane polarization183,184. Thus, conductivity alone is not a sufficient predictor of ES efficacy; rather, scaffold design must balance electrical properties with biological compatibility and spatial architecture to ensure that stimuli reach the embedded cells in a physiologically meaningful way. As graphene-based systems continue to advance, electrical delivery, cell viability, matrix production, tissue integration, and material behavior must be comprehensively assessed and validated. Experimental validation of graphene-based scaffolds in cartilage tissue engineering While graphene-based scaffolds in electrically stimulated systems have gained momentum, experimental validation often remains fragmented168. Many studies characterize only a subset of necessary parameters – such as scaffold composition, electrical inputs, or cellular outcomes – without fully assessing the stimulation environment or material properties. Critical variables such as graphene chemistry, mechanical properties, layer number, conductivity, and defect density are frequently unreported, and electrical field modeling is rarely performed to understand how scaffold geometry influences the electrical stimulus. Biological evaluation in 3D environments is often limited to surface-level observations, with few studies integrating molecular signaling, ECM composition, and cell organization into a unified framework. There is a need for coupled materials and biomolecular characterization techniques to fully elucidate graphene’s structure, property, performance correlations, and the impact on cellular signaling pathways. Addressing these gaps requires a more systematic validation strategy that supplements traditional cell-based assays with advanced characterization techniques. Core methodologies that can strengthen this framework include structural and chemical analyses such as Raman spectroscopy, X-ray photoelectron spectroscopy (XPS), Fourier transform infrared spectroscopy (FTIR), SEM, transmission electron microscopy (TEM), and atomic force microscopy to assess graphene quality, composition, and nanoscale topography. Electrical characterization should go beyond nominal inputs and include current-voltage curves, cyclic voltammetry, and electrochemical impedance spectroscopy (EIS) measurements, supported by in situ monitoring, to verify waveform fidelity and consistent stimulus delivery. Mechanical testing including DMA, nanoindentation, or shear testing, can quantify both bulk and localized responses under physiological loading. To evaluate 3D spatial organization, techniques like MicroCT, cryo-EM with contrast agents, and coated or labeled SEM can help visualize cell distribution and ECM integration in systems that limit spatial resolution due to scaffold properties (e.g., opacity or thickness). Modeling approaches like finite element analysis or tortuosity-informed field mapping can further clarify how scaffold architecture influences local stimulation. In conjunction with core techniques, Ca2+ flux imaging, membrane potential imaging, and mass spectrometry-based proteomics offer valuable insight into how ES modulates intracellular signaling, electrophysiological activity, and global protein expression. Finally, time-course studies, high-throughput screening platforms, and real-time monitoring systems can provide dynamic, scalable assessments of scaffold performance over extended culture periods. Together, these approaches represent a flexible yet comprehensive experimental toolkit for evaluating graphene-based scaffolds in electrically stimulated cartilage TE systems. Limitations and Future Perspectives Despite meaningful progress in developing graphene-based scaffolds for cartilage tissue engineering, the field remains constrained by several foundational gaps that must be addressed before translational impact is achievable. A central limitation is the persistent inconsistency in material terminology. Many studies report the use of “graphene” while in practice employing GO, rGO, FLG, or hybrid derivatives with fundamentally different surface chemistries, defect densities, and electronic properties. Collapsing these materials under a single label obscures structure–function relationships and prevents rigorous comparison across studies. Establishing precise, chemistry-aware nomenclature is not a semantic exercise — it is essential for reproducibility, mechanistic interpretation, and regulatory clarity. Benchmarking practices present a second barrier. Graphene-enhanced scaffolds are frequently evaluated against controls such as glass, PDMS, or low-modulus hydrogels that bear little resemblance to the structural, mechanical, or biochemical environment of native cartilage. These comparisons inflate perceived performance gains while offering limited insight into how graphene scaffolds perform relative to clinically relevant materials or next-generation electroactive composites. Future studies must adopt physiologically grounded baselines and report performance metrics under cartilage-appropriate loading, lubrication, and degradation conditions. Mechanistic understanding remains similarly underdeveloped. While numerous studies document increases in ECM deposition or chondrogenic gene expression, few interrogate the upstream signaling pathways that drive these outcomes. High-content tools such as RNA sequencing, phosphoproteomics, and spatial transcriptomics are increasingly accessible, yet functional validation — through pathway inhibition, knockdown, or reporter systems — is rarely implemented. Without these approaches, the field cannot distinguish graphene-specific effects from generic responses to stiffness, charge, or nanoscale topography. A mechanistic framework that integrates biophysical cues, electroactivity, and cell-matrix signaling will be essential for rational scaffold design. Mechanical performance, although promising, remains inconsistently optimized. Reported improvements in modulus, toughness, and fatigue resistance vary widely with graphene concentration, flake size, reduction state, and fabrication method. In many cases, reinforcement mechanisms are inferred rather than directly measured, and the contribution of graphene is confounded by changes in polymer chemistry or crosslinking density. Long-term durability under physiologic loading, degradation kinetics, and the coupling between mechanical performance and cell behavior remain largely unexplored. Addressing these gaps will require standardized mechanical testing protocols and in situ characterization tools capable of capturing dynamic scaffold behavior. Finally, it is important to recognize that graphene has served as the gateway material, introducing 2D nanomaterials to the broader tissue engineering community. Its early success in hydrogels, polymer composites, and electroactive scaffolds established the experimental playbook for integrating atomically thin materials into biological systems. This foundation now enables systematic exploration of emerging 2D materials — including MXenes, transition metal dichalcogenides (TMDs), and hexagonal boron nitride (hBN) — each offering distinct combinations of conductivity, surface chemistry, catalytic activity, and mechanical behavior. A major future direction will be rigorous benchmarking of these materials against graphene, particularly in the rapidly expanding field of bioinks, where printability, rheology, crosslinking behavior, and cell compatibility must be evaluated alongside electrochemical and mechanical performance. Establishing comparative frameworks across the 2D materials family will be essential for identifying which chemistries are best suited for specific biological functions and for advancing beyond graphene toward a new generation of multifunctional, stimuli-responsive bioinks. Looking forward, the field must move toward standardized material characterization, mechanistically informed biological studies, and integrated bioelectronic systems capable of applying and monitoring multimodal stimuli (Fig. 15). These advances will enable the community to link graphene’s unique physicochemical properties — and those of emerging 2D materials — to specific cellular outcomes in a reproducible, quantifiable, and clinically meaningful manner. Only through this level of rigor can graphene-based and 2D-material-based scaffolds transition from promising experimental platforms to viable candidates for cartilage repair and regeneration.Fig. 15Conceptual overview of current challenges, emerging material opportunities, and translational pathways for 2D-material–based cartilage tissue engineering leading to multimodal platforms that integrate custom scaffolds, additive manufacturing for engineered bioreactors, and real-time monitoring to enable rigorous evaluation. Conceptual overview of current challenges, emerging material opportunities, and translational pathways for 2D-material–based cartilage tissue engineering leading to multimodal platforms that integrate custom scaffolds, additive manufacturing for engineered bioreactors, and real-time monitoring to enable rigorous evaluation. Conclusions Graphene-based materials offer a compelling platform for advancing cartilage TE, with the potential to address longstanding challenges in scaffold design, mechanical reinforcement, and bioactive modulation. Their unique combination of conductivity, tunable chemistry, and structural versatility enables integration across a range of scaffold formats and stimulation paradigms. However, the field remains limited by inconsistent material characterization, inadequate benchmarking, and lack of mechanistic insight into how these materials influence cellular behavior – particularly under electrically stimulated conditions. A more rigorous and integrated experimental framework is needed to evaluate graphene-based scaffolds across structural, electrical, mechanical, and biological dimensions. The following chapters aim to address these gaps by combining precision-engineered graphene scaffolds with scaffold-coupled electrical stimulation, real-time waveform monitoring, and detailed material analysis, including Raman spectroscopy, X-ray photoelectron spectroscopy, and microscale topography. These tools are integrated with modeled electric-field distributions, spatial and volumetric analyses of cellular organization, and quantitative assessments of mechanical performance and proteomic signatures—establishing a foundation for mechanistically informed, electroactive GF scaffolds for cartilage regeneration.